Skip to main navigation

Eiger - Header Menu

About
- Team
Investors
Programs
Resources

Eiger - Header Menu

About
- Team
Investors
Programs
Resources

Investors

Press Releases

Year

Date

Latest Press Release

March 28, 2016

Eiger BioPharmaceuticals Granted Orphan Medicinal Product Designation for Ubenimex in Pulmonary Arterial Hypertension by European Medicines Agency

March 22, 2016

Eiger BioPharmaceuticals Closes Merger With Celladon

Pagination

First page
Previous page
…
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Current page 17

Eiger - Shareholder Tools

Print Page
Contact Us
RSS Feeds
Email Alerts
IR Contacts

Use of this website is governed by the Terms and Conditions and Privacy Policy.

Copyright ©2019 Eiger BioPharmaceuticals. All Rights Reserved. 06/19 XX-XX-XXXX

Use of this website is governed by the Terms and Conditions and Privacy Policy.

Copyright ©2019 Eiger BioPharmaceuticals. All Rights Reserved. 06/19 XX-XX-XXXX